Insmed Inc (INSM)

(10% Negative) INSMED INCORPORATED (INSM) Announces Delay in point Trials for launching new product Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment